Menu

Image of the Day: Throw the Switch

A computer model of the eye can predict the consequences of altering the neural pathways of vision.

Jun 27, 2018
Sukanya Charuchandra

ABOVE: Horizontal cells of mice
DRINNENBERG ET AL.

Acomputer model of the mouse retina both reiterated experimental results and predicted outcomes of toying with specific neurons, according to findings published in Neuron on June 21. Researchers suggest the simulation could be used to forecast the results of eye diseases. 

The scientists tweaked a type of neuron, called a horizontal cell, which acts as a go-between for the input and output cells in the retina. By switching this type of cell on and off in mice, the scientists recorded a wide range of responses to the interference. 

Their computer simulation corroborated the observations in mice and made other predictions about the responses of horizontal cells that the scientists validated.

“One way to test our understanding of the retina is to perturb one of its elements, measure all the outputs, and see if our ‘understanding,’ which is a model, can predict the observed changes,” Rava da Silveira, a coauthor on the paper, says in a statement

A. Drinnernberg et al., “How diverse retinal functions arise from feedback at the first visual synapse,” Neuron, doi:10.1016/j.neuron.2018.06.001, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.